Rocket Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $566.3M
Liabilities Breakdown FY2023
Total Liabilities: $73.8M
Asset Breakdown
Total Assets: $566.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $55.9M | 9.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $39.2M | 6.9% |
| Goodwill | $39.2M | 6.9% |
| Intangible Assets | $25.2M | 4.4% |
| Other Assets | $407.0M | 71.9% |
Liabilities Breakdown
Total Liabilities: $73.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $73.8M | 100.0% |